- Apr 3

Development of novel therapies for pediatric cancer: Successes and challenges

Peter J. Houghton from Greehey Children’s Cancer Research Institute and Mary-Ann Bjornsti from the University of Alabama discuss some of the key challenges in the development of therapies for pediatric cancer care.

Comments

Strength in numbers: Cooperative group clinical trials move the needle against pediatric cancer

FDA Grants Orphan Drug Designation to Opaganib in Neuroblastoma

After my daughter's cancer, I wanted to control her entire life. Then she went to college.

When Childhood Cancer Survivors Face Sexual Challenges

Early interventions may improve long-term academic achievement in young childhood brain tumor survivors

Immunotherapy for children with primary liver carcinomas: Research offers new hope

Pediatric psychologist explains how to support your child's development after a cancer diagnosis

Adult Survivors of Childhood Cancer Have High Prevalence of Chronic Pain

Spontaneous Remission in Childhood Cancer Rare but Fleeting

First successful treatment of pediatric high-risk refractory neuroblastoma with PARP inhibition

Recent Posts

Development of novel therapies for pediatric cancer: Successes and challenges

Comments

Archive

Search By Tags